Akorn Inc. (AKRX)

19.14 -0.01 (-0.052%)

IEX Real-Time Price

9:32:41 AM EST.

Nasdaq Global Select : Healthcare

Prev Close 19.15

Price Open 19.49

Volume: 17,167

Avg Volume: 2.34M

Market Cap: 2.4B

P/E Ratio -

52 Wk Range 10.755-33.63



AKRX Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-07-31
120.54M
10.86M
3.76
9.01%

2018-07-13
120.35M
10.97M
3.13
9.12%

2018-06-29
120.35M
12.26M
5.30
10.19%

2018-06-15
120.35M
9.79M
5.63
8.14%




AKRX Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2017-03-01
Q4 2016
BTO
0.55 (7)
0.56
0.01

2016-11-03
Q3 2016
BTO
0.52 (7)
0.53
0.01

2016-08-04
Q2 2016
BTO
0.53 (7)
0.56
0.03

2016-05-16
Q1 2016
AMC
0.53 (3)
0.53
0.00

News

FDA OKs first generic drug under new accelerated pathway (2018-08-08 11:38 SeekingAlpha)

The FDA has approved Apotex's potassium chloride oral solution for the treatment and prevention of hypokalemia (low blood potassium) in patients on diuretics and when dietary management with potassium-rich foods is inadequate or diuretic dose reduction is not possible. More news on: Myla…

 

Mylan's trimmed guidance may pressure generic drug makers (2018-08-08 09:07 SeekingAlpha)

Mylan (NASDAQ: MYL ) is under modest pressure premarket, down 5% on average volume, after cutting its 2018 guidance due to continued challenges in the U.S. market, a move that could stoke selling in the generics space. More news on: Mylan Inc, Teva Pharmaceutical Industries Lim…

 


Statistics

Shares Outstanding: 125.45M

Top 15 Institution Percent: 65.90

Price To Sales: 3.17

Price To Book: 3.36

Revenue: N/A

Gross Profit: N/A

Cash: N/A

Debt: N/A

Return On Assets: -9.77

Return On Equity: -23.00

Profit Margin: -24.21

Price History

Beta: 2.03

50-day Moving Avg: 17.13

200-day Moving Avg: 23.10

YTD Change: -41.38

5-day Change: 3.01

1-month Change: 13.72

3-month Change: 36.40

6-month Change: -39.87

1-year Change: -42.49

Revenue Per Share: 0.00

Revenue Per Employee: 0.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Akorn Inc.

Exchange: Nasdaq Global Select

Industry: Drug Manufacturers

Sector: Healthcare

Website: http://www.akorn.com

Akorn Inc is a United States based generic pharmaceutical company. It develops, manufactures and markets generic and branded prescription pharmaceuticals as well as private-label over-the-counter consumer health products and animal health pharmaceuticals.